INTERMEDIATES
*
|
Name of Product | 3-Nitro
Phthalic Acid
| |
Structural Formula | 
| |
Molecular Formula |
C8H5NO6 |
| CAS NO. |
603-11-2 | |
Synonyms | 3-Nitro-1,2-Benzenedicarboxylic
Acid | |
Usage | Candesartan cilexetil / Electro
Chemicals / Anti corrosive varnishes,Agro chemicals |
| Packing |
50 Kg Fibre Drums | |
Technical Specification |
| Appearance |
: | White to Offwhite Crystalline Powder
| | Assay | :
| Not Less Than 99% | |
Mol. Wt | : | 211.13 |
|
|
Name of Product | 3-Nitro
Phthalonitrile
| |
Structural Formula | 
| |
Molecular Formula |
C8H3N3O2 |
| CAS NO. |
51762-67-5 | |
Synonyms | 2,3 Dicyano-1-Nitrobenzene
| |
Usage | Phathlocyanine Beta Blue (
Pigment Beta Blue 15:3 ) Pestisides, Drug Intermediate |
| Packing |
25 Kg Fibre Drums | |
Technical Specification |
| Appearance |
: | White to Off White Crystaline Powder
| | Assay | :
| Not Less Than 99% | |
Mol. Wt | : | 173.13 |
|
|
Name of Product | 3-Nitro
Phthalic Anhydride
| |
Structural Formula | 
| |
Molecular Formula |
C8H3NO5 |
| CAS NO. |
641-70-3 | |
Usage | CD Coating / Other Uses |
| Packing |
25 Kg Fibre Drums | |
Technical Specification |
| Appearance |
: | Light Yellow Crystaline Powder |
| Assay | : |
Not Less Than 97% | | Mol. Wt |
: | 193.11 | |
|
Name of Product | 4-Nitro
Phthalic Acid
| |
Structural Formula | 
| |
Molecular Formula |
C8H5NO6 |
| CAS NO. |
610-27-5 | |
Usage | Agrochemicals |
| Packing |
50 Kg Fibre Drums | |
Technical Specification |
| Appearance |
: | White to Yellow Powder |
| Assay | : |
Not Less Than 97% | | Mol. Wt |
: | 211.13 | |
|
Name of Product | 4-Nitro
Phthalic Anhydride
| |
Structural Formula | 
| |
Molecular Formula |
C8H3NO5 |
| CAS NO. |
5466-84-2 | |
Usage | Pigment Drug Intermediate |
| Packing |
25 Kg Fibre Drums | |
Technical Specification |
| Appearance |
: | White to Off White Crystalline Powder
| | Assay | :
| Not Less Than 90% | |
Mol. Wt | : | 193.11 |
| Note: DMF
Available on request.
*The technical and physical manufacturing capabilities
exists with us for these API and their intermediates, however these products will
not be offered to the markets where any product or process patents are not infringing.
During the validity of a patent the research quantities for developing products
for regulatory submissions will be offered only to countries where such exemption
exists (Hatch Waxman / Bolar exemption). While
OREX offers to take work with the clients on patent status verification,
the final responsibility vests with the buyer. Recipients are requested to make
their evaluation and determination as to the patent status prior to use the information
or material in their respective jurisdiction |
OREX PHARMA PRIVATE LIMITED
